Edwards Lifesciences Italia

Edwards Lifesciences Europe

Edwards Hemodynamic Monitoring

Edwards Surgical Structural Heart Therapies

Edwards Lifesciences España

Edwards Lifesciences (NYSE: EW), is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more.

Our roots date back to 1958 when Miles Lowell Edwards, a retired engineer with a background in hydraulics and fuel pump operations, set out to build the first artificial heart. Edwards believed the heart could be mechanized and was encouraged by Dr. Albert Starr to focus on developing an artificial heart valve. After just two years, the first Starr-Edwards mitral valve was developed and successfully placed in a patient. This innovation spawned Edwards Laboratories. Miles’ fascination with healing the heart and helping patients with heart disease stemmed from his own experience with rheumatic fever as a teenager and continues to fuel our patient-first culture today.

Today, we are as passionate about providing innovative solutions for people fighting cardiovascular disease as we have ever been. It's our Credo. It takes integrity, collaboration, innovation, and focus. We are leaders in the design and manufacture of tissue replacement heart valves and repair products as well as advanced hemodynamic monitoring. We partner with physicians to innovate products designed to help patients live longer, healthier, and more productive lives.

Our work is both rewarding and a privilege. The importance of what we do defines our approach. We work together to create an environment where ideas can flourish and we provide our people with the resources, expertise and support to bring those ideas to life.

For our legal terms and trademarks, please visit: https://www.edwards.com/legal/legal-terms 

Embrella Cardiovascular

Vascular Architects

Middle Peak Medical

Caption Health

Edwards Lifesciences

Today, we announced our Q4 2023 and full-year financial results. Read our #earnings release for Forward-Looking Statements and Non-GAAP Reconciliations here: https://lnkd.in/gFR4zZWq

#EWearnings #FinancialResults

Our Q4 2023 and full-year #earnings conference call will begin in 1 hour. Follow the link to join us: https://lnkd.in/eXwf4GMn

#EWearnings #FinancialResults

Join us tomorrow at 2 p.m. for a live webcast where we will share our Q4 2023 and full-year #FinancialResults.

Follow the link to join us: https://lnkd.in/eXwf4GMn

#EWearnings #earnings

Today, #EdwardsGoesRed to raise awareness of #HeartDisease in women. More than one in three women is living with some form of cardiovascular disease, but it’s often not recognized as the greatest health risk for women. Join us in spreading the word and getting the facts about heart disease in women: https://lnkd.in/ers5jsD
 
#WearRedDay #HeartMonth #GoRedForWomen #OurHeartsBeatWithEdwards

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve: https://lnkd.in/e-d_MU73

Edwards Learning Network

Edwards Masters

Edwards Clinical Education

Mitral & Tricuspid Valves

HEART MASTER Virtual Rounds

Viewfinder Remote

Edwards Connected Insights

Edwards Critical Care Pediatric Learning

Critical Care (German) eLearning

IPhone / Mobile Compatible

Viewport Meta

Domain Not Resolving

Euro

Apple Mobile Web Clips Icon

HSTS

DNSSEC

WordPress

LetsEncrypt

reCAPTCHA

Corporate VIce President, General Counsel.

Arnold Pinkston

President

Bernard Zovighian

Claston Edwards

Senior Vice President, Associate General Counsel, THV General Counsel & Chief Privacy Officer

Heather Haworth

Vice President, Assoc General Counsel

Jay Wertheim

SVP and Chief Information Security Officer

Kapil Assudani

Vice President Finance, Business Unit CFO - Structural Surgical Heart

Laura Egan

Senior Vice President Finance, Business Unit CFO - Critical Care

Mark Abbasi

Manufacturing Execution Systems Site Owner

Ryan Dunham

Sal Chiovari

William J. Link

Michael A. Mussallem

Nicholas Valeriani

Barbara McNeil

Martha H. Marsh

John T. Cardis

Steven Loranger

Michael Duncan

Murali Reddi

Principal, Medical Safety Officer

Shane Gleason

Senior Director, US Marketing- Transcatheter Heart Valves

Dirk Rassloff

Vice President Strategic Marketing, Surgical Structural Heart, Asia at Edwards Lifesciences

Uzair Siddiqui

Leader, Strategic Program Management

Nikolas Rizos

Strategy / Business Intelligence TMTT EU

Farzad Azimpour

Senior Vice President, Strategic Innovation, Advanced Technology

Nolan Sardesai

Sr. Product Manager

Christian Potes

Senior Director Applied Machine Learning Group

V-Wave is a medical device company that develops percutaneous implantable devices for patients with chronic heart failure.

Caption Health is a medical company that uses artificial intelligence (AI) to interpret ultrasound exams.

Endotronix is a developer of hemodynamic monitoring technologies to help detect worsening heart failure earlier than ever before.

Affluent Medical is develops innovative new-generation mini-invasive implants to restore essential physiological functions.

Vascular Architects are develops and markets devices to treat vascular disease and nonvascular obstructions.

Middle Peak Medical develops and commercializes a novel technology to treat mitral valve disease.

Embrella Cardiovascular is a medical device company that develops a system to improve embolic cerebral protection.

Medical Public Companies With More Than $100M in Revenue

Medical Public Companies With More Than $1B in Revenue

Health Care Companies With More Than $10M in Revenue (Top 10K)

Medical Public Companies With More Than 100 Employees

Edwards Lifesciences is a provider of science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives.

Irvine

California

United States

North America

Edwards reveals superior outcomes with Sapien 3 Ultra Resilia

Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data

EW LAWSUIT NOTICE: Edwards Lifesciences Investors are Notified of the Upcoming December 13 Deadline in Class Action Lawsuit – Contact BFA Law (NYSE:EW)

Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Edwards Lifesciences Corporation

Global Cardiovascular And Soft Tissue Repair Patches Market: Key Trends, Market Share, and Forecast for 2024-2033

After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation

Brazil

South America

Japan

Asia

Ireland

Europe

Norway

HTML5

Google Drive

Google Analytics

DigiCert

Google Tag Manager

jQuery

Microsoft Outlook

Office 365

Bootstrap

Modernizr

Edwards Lifesciences owns BD Advanced Patient Monitoring

Abbott Laboratories is a global healthcare company specializing in medical devices, diagnostics, branded generic pharmaceuticals, and nutritional products.

Abbott Laboratories

Medtronic plc is a global leader in medical technology, services, and solutions, focusing on improving healthcare by alleviating pain, restoring health, and extending life.

Medtronic plc

Stryker Corporation is a leading medical technology company offering a diverse array of innovative products and services in orthopedics, medical and surgical, and neurotechnology and spine.

Stryker Corporation

Boston Scientific Corporation is a global medical technology company that advances science for life by providing a broad range of high-performance solutions that address patient needs and improve the quality of healthcare.

Boston Scientific Corporation

Edwards Lifesciences is an American medical technology company specializing in artificial heart valves, critical care technology, and cardiac surgery technology. It is a global leader in patient-focused medical innovations for structural heart disease, critical care, and surgical monitoring.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

news impact assignment basic	general	Mar 7, 2024 4:11 PM	901f84fa
public peers	general
news daily refresh	general	Dec 4, 2024 2:16 PM	1f691522
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 7, 2024 4:11 PM	46633a80
company summary	general
signals	general	Mar 7, 2024 4:11 PM	651b0b54
crunchbase trigger	general	Nov 27, 2024 12:50 PM	e6e4676f
crunchbase profile	general	Nov 27, 2024 1:26 PM	20e56fdb
li profile	general	Mar 7, 2024 4:11 PM	17fd10fb
translate crunchbase fundingrounds	general	Nov 27, 2024 2:58 PM	5f893d29
peers	general	Mar 7, 2024 4:11 PM	bed8749c
news basic	general	Dec 4, 2024 2:13 PM	9ab39c43
bundesanzeiger	filings	Mar 7, 2024 4:11 PM	6ce984b3
financials download nd	financials
private financials	financials

COM:EDWARDS

Edwards Lifesciences Corporation

Last Close

70.38

22/11 21:00

Market Cap

56.51B

Beta: -

Volume Today

2.64M

Avg: -